Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 630 Prostatic Neoplasms 372 Neoplasms 305 Carcinoma, Non-Small-Cell Lung 215 Lung Neoplasms 204 Colorectal Neoplasms 176 Multiple Myeloma 143 Pancreatic Neoplasms 136 Leukemia, Myeloid, Acute 128 Neoplasm Metastasis 124 Brain Neoplasms 117 Melanoma 116 Ovarian Neoplasms 101 Carcinoma, Hepatocellular 101 Precursor Cell Lymphoblastic Leukemia-Lymphoma 100 Glioblastoma 99 Uterine Cervical Neoplasms 97 Head and Neck Neoplasms 94 Squamous Cell Carcinoma of Head and Neck 93 Colonic Neoplasms 82 Stomach Neoplasms 80 Recurrence 80 Rectal Neoplasms 80 Urinary Bladder Neoplasms 77 Sarcoma 77 Carcinoma, Renal Cell 76 Triple Negative Breast Neoplasms 75 Lymphoma 71 Lymphoma, Non-Hodgkin 67 Leukemia, Lymphocytic, Chronic, B-Cell 66

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × OTHER × Advanced NSCLC × Clear all

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡